Additive manufacturing processes such as 3D printing use time-consuming, stepwise layer-by-layer approaches to object fabrication. We demonstrate the continuous generation of monolithic polymeric parts up to tens of centimeters in size with feature resolution below 100 micrometers. Continuous liquid interface production is achieved with an oxygen-permeable window below the ultraviolet image projection plane, which creates a "dead zone" (persistent liquid interface) where photopolymerization is inhibited between the window and the polymerizing part. We delineate critical control parameters and show that complex solid parts can be drawn out of the resin at rates of hundreds of millimeters per hour. These print speeds allow parts to be produced in minutes instead of hours.
Microneedles, arrays of micron-sized needles that painlessly puncture the skin, enable transdermal delivery of medications that are difficult to deliver using more traditional routes. Many important design parameters, such as microneedle size, shape, spacing, and composition, are known to influence efficacy, but are notoriously difficult to alter due to the complex nature of microfabrication techniques. Herein, we utilize a novel additive manufacturing (“3D printing”) technique called Continuous Liquid Interface Production (CLIP) to rapidly prototype sharp microneedles with tuneable geometries (size, shape, aspect ratio, spacing). This technology allows for mold-independent, one-step manufacturing of microneedle arrays of virtually any design in less than 10 minutes per patch. Square pyramidal CLIP microneedles composed of trimethylolpropane triacrylate, polyacrylic acid and photopolymerizable derivatives of polyethylene glycol and polycaprolactone were fabricated to demonstrate the range of materials that can be utilized within this platform for encapsulating and controlling the release of therapeutics. These CLIP microneedles effectively pierced murine skin ex vivo and released the fluorescent drug surrogate rhodamine.
Purpose Microneedle patches are arrays of tiny needles that painlessly pierce the skin to deliver medication into the body. Biocompatible microneedles are usually fabricated via molding of a master structure. Microfabrication techniques used for fabricating these master structures are costly, time intensive, and require extensive expertise to control the structure’s geometry of the structure, despite evidence that microneedle geometry is a key design parameter. Here, a commercially available 3D printer is utilized, for the first time, to quickly and easily manufacture microneedle masters. Design/methodology/approach Because commercially available 3D printers are not typically used for micron-scale fabrication, the influence of three different sources of error- stair-stepping, aliasing, and light abberations- on the resulting structure is investigated. A custom Matlab code is written to control the light intensity projected off of each individual micromirror (through grayscale) at a given time. The effect of the layer height, the number of layers, and grayscale on the sharpness, surface texture, and dimensional fidelity of the final structure is described. Findings The Autodesk Ember is successfully utilized to fabricate sharp microneedles with a tip radius of approximately 15 μm in less than 30 min per patch (as compared to weeks to months for existing approaches). Utilization of grayscale improves surface texture and sharpness, and dimensional fidelity within ±5% of desired dimensions is achieved. Originality/value The described 3D printing technique enables investigators to accurately fabricate microneedles within minutes at low cost. Rapid, iterative optimization of microneedle geometry through 3D printing will accelerate microneedle research through improved understanding of the relationship between microneedle structure and function. Electronic supplementary material The online version of this article (10.1186/s41205-019-0039-x) contains supplementary material, which is available to authorized users.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.